Stada has been in the middle of an acquisition talk in last couple of days as it has confirmed that at least two bidders were competing to buy this German pharmaceutical company.
On Thursday, STADA Arzneimittel AG confirmed that it has received another legally non-binding conditional expression of interest regarding a bid for the acquisition of up to 100 percent of the shares in the company at an indicative takeover price of €58.00 per share.
The company earlier said that one of the bidders was a private investment company Cinven, but said it was thinking about the offers.
“It is not yet possible to foresee whether one or more takeover offers of the three potential bidders will indeed materialise. STADA will keep both the capital markets and the public updated on tangible development in this regard, in line with the applicable legal requirements,” Stada said.